PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31912804-0	2020	Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-kappaB) Signaling Pathway.	Dexmedetomidine	0-15	toll-like receptor 4	Rattus norvegicus	149-169	
31912804-0	2020	Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-kappaB) Signaling Pathway.	Dexmedetomidine	0-15	toll-like receptor 4	Rattus norvegicus	171-175	
31912804-3	2020	In this study, the effects of dexmedetomidine post-conditioning on the HMGB1/TLR4/NF-kappaB signaling pathway in cerebral ischemia-reperfusion rats was explored.	Dexmedetomidine	30-45	toll-like receptor 4	Rattus norvegicus	77-81	
31912804-10	2020	CONCLUSIONS Dexmedetomidine post-conditioning can alleviate cerebral ischemia-reperfusion injury in rats by inhibiting the HMGB1/TLR4/NF-kappaB signaling pathway.	Dexmedetomidine	12-27	toll-like receptor 4	Rattus norvegicus	129-133